Skip to main content
SpringerLink
Log in

Overview of the Comorbidity Between Medical Illnesses and Overweight/Obesity

  • Chapter
  • First Online:
Comorbidity

Abstract

Overweight and obesity are major contributors to the total global burden of chronic diseases due to the consequences of their associated comorbid conditions which can affect all systems of the body. These comorbidities are often considered to be consequence of the excess weight with unidirectional causality; however, causality is almost certainly multidirectional with roles for both physical and psychological factors. In this chapter, an overview of overweight- and obesity-related medical illnesses, categorised according to the body systems affected, is provided. Some focus is directed towards the role of the metabolic syndrome in these illnesses. The importance of causality of comorbid conditions at early, middle and late stages of disease is emphasised, as interventions targeting causalities at each of these times are likely to have the greatest impact on lessening the burden of overweight and obesity on affected individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. GBD Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine. 2017;377(1):13–27. https://doi.org/10.1056/nejmoa1614362.

  2. Gregg EW, Shaw JE. Global health effects of overweight and obesity. New England Journal of Medicine. 2017;377(1):80–81. https://doi.org/10.1056/nejme1706095.

    Article  PubMed  Google Scholar 

  3. Chu DT, Minh Nguyet NT, Dinh TC, et al. An update on physical health and economic consequences of overweight and obesity. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;12(6):1095–1100. https://doi.org/10.1016/j.dsx.2018.05.004.

    Article  Google Scholar 

  4. Catalano PM, Shankar K. Obesity and pregnancy: Mechanisms of short term and long term adverse consequences for mother and child. British Medical Journal. 2017;356:j1. https://doi.org/10.1136/bmj.j1.

  5. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: From pathophysiology to prevention and management. The Lancet. 2011;378(9786):169–181. https://doi.org/10.1016/s0140-6736(11)60614-4.

    Article  Google Scholar 

  6. Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB. Obesity as a disease: The obesity society 2018 position statement. Obesity. 2019;27(1):7–9. https://doi.org/10.1002/oby.22378.

    Article  Google Scholar 

  7. World Health Organisation. Obesity: Preventing and managing the global epidemic: Report of a WHO Consultation. Geneva, Switzerland: World Health Organisation; 2000.

    Google Scholar 

  8. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet. 2004;363(9403):157–163. https://doi.org/10.1016/s0140-6736(03)15268-3.

  9. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016. The Journal of the American Medical Association. 2018;319(16):1723–1725. https://doi.org/10.1001/jama.2018.3060.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607.

    Article  PubMed  Google Scholar 

  11. Nolan CJ, Prentki M. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. Diabetes and Vascular Disease Research. 2019;16(2):118–127. https://doi.org/10.1177/1479164119827611.

    Article  PubMed  Google Scholar 

  12. Sperling LS, Mechanick JI, Neeland IJ, et al. The cardiometabolic health alliance: Working toward a new care model for the metabolic syndrome. Journal of the American College of Cardiology. 2015;66(9):1050–1067. https://doi.org/10.1016/j.jacc.2015.06.1328.

    Article  PubMed  Google Scholar 

  13. Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocrine Reviews. 2008;29(7):777–822. https://doi.org/10.1210/er.2008-0024.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lim SS, Kakoly NS, Tan JWJ, et al. Metabolic syndrome in polycystic ovary syndrome: A systematic review, meta-analysis and meta-regression. Obesity Reviews. 2018;20(2):339–352. https://doi.org/10.1111/obr.12762.

    Article  PubMed  Google Scholar 

  15. Farrell GC, Haczeyni F, Chitturi S. Pathogenesis of NASH: How metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease. Advances in Experimental Medicine and Biology. 2018;1061:19–44. https://doi.org/10.1007/978-981-10-8684-7_3.

    Google Scholar 

  16. Kazemi M, Pierson RA, Lujan ME, et al. Comprehensive evaluation of type 2 diabetes and cardiovascular disease risk profiles in reproductive-age women with polycystic ovary syndrome: A large Canadian cohort. Journal of Obstetrics and Gynaecology Canada. In press. https://doi.org/10.1016/j.jogc.2018.11.026.

    Article  PubMed  Google Scholar 

  17. Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002;35(2):373–379. https://doi.org/10.1053/jhep.2002.30692.

    Article  PubMed  Google Scholar 

  18. Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: A cardiometabolic risk in obesity and the metabolic syndrome. Journal of the American College of Cardiology. 2013;62(7):569–576. https://doi.org/10.1016/j.jacc.2013.05.045.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Baffi CW, Wood L, Winnica D, et al. Metabolic syndrome and the lung. Chest. 2016;149(6):1525–1534. https://doi.org/10.1016/j.chest.2015.12.034.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Joyce T, Chirino YI, Natalia MT, Jose PC. Renal damage in the metabolic syndrome (MetSx): Disorders implicated. European Journal of Pharmacology. 2018;818:554–568. https://doi.org/10.1016/j.ejphar.2017.11.032.

    Article  PubMed  Google Scholar 

  21. Kim B, Feldman EL: Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Experimental and Molecular Medicine. 2015;47(3):e149. https://doi.org/10.1038/emm.2015.3.

    Article  Google Scholar 

  22. Tobin AM, Ahern T, Rogers S, Collins P, O’Shea D, Kirby B. The dermatological consequences of obesity. International Journal of Dermatology. 2013;52(8):927–932. https://doi.org/10.1111/j.1365-4632.2012.05624.x.

    Article  PubMed  Google Scholar 

  23. Simmons RK, Alberti KG, Gale EA, et al. The metabolic syndrome: Useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010;53(4):600–605. https://doi.org/10.1007/s00125-009-1620-4.

    Article  PubMed  Google Scholar 

  24. Kakoly NS, Earnest A, Teede HJ, Moran LJ, Joham AE. The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care. 2019;42(4):560–567. https://doi.org/10.2337/dc18-1738.

    Article  PubMed  Google Scholar 

  25. Tomlinson J, Millward A, Stenhouse E, Pinkney J. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: What are the risks and can they be reduced? Diabetic Medicine. 2010;27(5):498–515.

    Article  PubMed  Google Scholar 

  26. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22(1):141–146. https://doi.org/10.2337/diacare.22.1.141.

    Article  PubMed  Google Scholar 

  27. Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. Journal of Hepatology. 2016;65(3):589–600. https://doi.org/10.1016/j.jhep.2016.05.013.

    Article  PubMed  Google Scholar 

  28. Zimmet P, Alberti K, Stern N, et al. The Circadian Syndrome: Is the metabolic syndrome and much more! Journal of Internal Medicine. 2019. https://doi.org/10.1111/joim.12924.

  29. Weaver JU. Classical endocrine diseases causing obesity. Obesity and Metabolism. 2008;36:212–228. https://doi.org/10.1159/000115367.

    Chapter  Google Scholar 

  30. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. The Lancet. 2017;390(10101):1550–1562. https://doi.org/10.1016/s0140-6736(17)30703-1.

    Article  Google Scholar 

  31. Nieman LK. Cushing’s syndrome: Update on signs, symptoms and biochemical screening. European Journal of Endocrinology. 2015;173(4):M33–M38. https://doi.org/10.1530/eje-15-0464.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Naderpoor N, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ. Obesity and polycystic ovary syndrome. Minerva Endocrinologica. 2015;40(1):37–51.

    Google Scholar 

  33. van der Valk ES, van den Akker ELT, Savas M, et al. A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obesity Reviews. 2019;20(6):795–804. https://doi.org/10.1111/obr.12836.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. The Lancet. 2017;389(10085):2239–2251. https://doi.org/10.1016/s0140-6736(17)30058-2.

    Article  Google Scholar 

  35. Schaefer-Graf U, Napoli A, Nolan CJ. Diabetic Pregnancy Study G. Diabetes in pregnancy: A new decade of challenges ahead. Diabetologia. 2018;61(5):1012–1021. https://doi.org/10.1007/s00125-018-4545-y.

  36. Belenkaia LV, Lazareva LM, Walker W, Lizneva DV, Suturina LV. Criteria, phenotypes and prevalence of polycystic ovary syndrome. Minerva Ginecologica. 2019;71(3):211–223. https://doi.org/10.23736/s0026-4784.19.04404-6.

  37. Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. International Journal of Environmental Research and Public Health. 2018;15(11):2589. https://doi.org/10.3390/ijerph15112589.

    Article  PubMed Central  Google Scholar 

  38. Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: A systematic review and meta-analysis. Human Reproduction Update. 2012;18(6):618–637. https://doi.org/10.1093/humupd/dms030.

    Article  PubMed  Google Scholar 

  39. El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly cystic ovarian syndrome: An updated overview. Frontiers in Physiology. 2016;7:124. https://doi.org/10.3389/fphys.2016.00124.

  40. Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ. Emotional distress is a common risk in women with polycystic ovary syndrome: A systematic review and meta-analysis of 28 studies. Human Reproduction Update. 2012;18(6):638–651. https://doi.org/10.1093/humupd/dms029.

    Article  PubMed  Google Scholar 

  41. Damone AL, Joham AE, Loxton D, Earnest A, Teede HJ, Moran LJ. Depression, anxiety and perceived stress in women with and without PCOS: A community-based study. Psychological Medicine. 2019;49(9):1510–1520. https://doi.org/10.1017/s0033291718002076.

    Article  PubMed  Google Scholar 

  42. Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. The Journal of Clinical Endocrinology & Metabolism. 2015;100(3):911–919. https://doi.org/10.1210/jc.2014-3886.

    Article  Google Scholar 

  43. O’Brien PD, Hinder LM, Callaghan BC, Feldman EL. Neurological consequences of obesity. The Lancet Neurology. 2017;16(6):465–477. https://doi.org/10.1016/s1474-4422(17)30084-4.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: A meta-analysis of prospective studies. Obesity Reviews. 2011;12(5):e426–e437. https://doi.org/10.1111/j.1467-789x.2010.00825.x.

    Article  PubMed  Google Scholar 

  45. Pedditzi E, Peters R, Beckett N. The risk of overweight/obesity in mid-life and late life for the development of dementia: A systematic review and meta-analysis of longitudinal studies. Age and Ageing. 2016;45(1):14–21. https://doi.org/10.1093/ageing/afv151.

    Article  Google Scholar 

  46. Qizilbash N, Gregson J, Johnson ME, et al. BMI and risk of dementia in two million people over two decades: A retrospective cohort study. The Lancet Diabetes & Endocrinology. 2015;3(6):431–436. https://doi.org/10.1016/s2213-8587(15)00033-9.

    Article  Google Scholar 

  47. Sabia S, Kivimaki M, Shipley MJ, Marmot MG, Singh-Manoux A. Body mass index over the adult life course and cognition in late midlife: The Whitehall II cohort study. The American Journal of Clinical Nutrition. 2009;89(2):601–607. https://doi.org/10.3945/ajcn.2008.26482.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Mrak RE. Alzheimer-type neuropathological changes in morbidly obese elderly individuals. Clinical Neuropathology. 2009;28(1):40–45.

    Article  PubMed  Google Scholar 

  49. Taki Y, Kinomura S, Sato K, et al. Relationship between body mass index and gray matter volume in 1,428 healthy individuals. Obesity. 2008;16(1):119–124. https://doi.org/10.1038/oby.2007.4.

    Article  PubMed  Google Scholar 

  50. Jagust W, Harvey D, Mungas D, Haan M. Central obesity and the aging brain. Archives of Neurology. 2005;62(10):1545–1548. https://doi.org/10.1001/archneur.62.10.1545.

  51. Pannacciulli N, Del Parigi A, Chen K, Le DS, Reiman EM, Tataranni PA. Brain abnormalities in human obesity: A voxel-based morphometric study. Neuroimage. 2006;31(4):1419–1425. https://doi.org/10.1016/j.neuroimage.2006.01.047.

    Article  PubMed  Google Scholar 

  52. Raji CA, Ho AJ, Parikshak NN, et al. Brain structure and obesity. Human Brain Mapping. 2010;31(3):353–364. https://doi.org/10.1002/hbm.20870.

  53. Yau PL, Castro MG, Tagani A, Tsui WH, Convit A. Obesity and metabolic syndrome and functional and structural brain impairments in adolescence. Pediatrics. 2012;130(4):e856–864. https://doi.org/10.1542/peds.2012-0324.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Alosco ML, Stanek KM, Galioto R, et al. Body mass index and brain structure in healthy children and adolescents. International Journal of Neuroscience. 2014;124(1):49–55. https://doi.org/10.3109/00207454.2013.817408.

    Article  PubMed  Google Scholar 

  55. Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer’s disease. The Lancet Neurology. 2015;14(4):388–405. https://doi.org/10.1016/s1474-4422(15)70016-5.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Polsek D, Gildeh N, Cash D, et al. Obstructive sleep apnoea and Alzheimer’s disease: In search of shared pathomechanisms. Neuroscience & Biobehavioral Reviews. 2018;86:142–149. https://doi.org/10.1016/j.neubiorev.2017.12.004.

    Article  Google Scholar 

  57. Alfaro FJ, Gavrieli A, Saade-Lemus P, Lioutas VA, Upadhyay J, Novak V. White matter microstructure and cognitive decline in metabolic syndrome: A review of diffusion tensor imaging. Metabolism. 2018;78:52–68. https://doi.org/10.1016/j.metabol.2017.08.009.

    Article  PubMed  Google Scholar 

  58. Salameh TS, Rhea EM, Banks WA, Hanson AJ. Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer’s disease. Experimental Biology and Medicine. 2016;241(15):1676–1683. https://doi.org/10.1177/1535370216660770.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Dewan NA, Nieto FJ, Somers VK. Intermittent hypoxemia and OSA: Implications for comorbidities. Chest. 2015;147(1):266–274. https://doi.org/10.1378/chest.14-0500.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Clark IA, Alleva LM, Vissel B. The roles of TNF in brain dysfunction and disease. Pharmacology and Therapeutics. 2010;128(3):519–548. https://doi.org/10.1016/j.pharmthera.2010.08.007.

    Article  Google Scholar 

  61. Thorp AA, Schlaich MP. Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. Journal of Diabetes Research. 2015;2015:341583. https://doi.org/10.1155/2015/341583.

    Article  Google Scholar 

  62. Balasubramanian P, Hall D, Subramanian M. Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases. Geroscience. 2019;41(1):13–24. https://doi.org/10.1007/s11357-018-0048-5.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Canale MP, Manca di Villahermosa S, Martino G, et al. Obesity-related metabolic syndrome: Mechanisms of sympathetic overactivity. International Journal of Endocrinology. 2013;2013:865965. https://doi.org/10.1155/2013/865965.

    Article  Google Scholar 

  64. Callaghan BC, Xia R, Banerjee M, et al. Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status. Diabetes Care. 2016;39(5):801–807. https://doi.org/10.2337/dc16-0081.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Karelis AD. Metabolically healthy but obese individuals. The Lancet. 2008;372(9646):1281–1283. https://doi.org/10.1016/s0140-6736(08)61531-7.

    Article  Google Scholar 

  66. Hinnouho GM, Czernichow S, Dugravot A, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: The Whitehall II cohort study. European Heart Journal. 2015;36(9):551–559. https://doi.org/10.1093/eurheartj/ehu123.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. JAMA Internal Medicine. 2014;174(1):15–22. https://doi.org/10.1001/jamainternmed.2013.10522.

    Article  PubMed  Google Scholar 

  68. Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010;121(2):230–236. https://doi.org/10.1161/circulationaha.109.887521.

    Article  PubMed  Google Scholar 

  69. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. New England Journal of Medicine. 2002;347(5):305–313. https://doi.org/10.1056/nejmoa020245.

    Article  PubMed  Google Scholar 

  70. Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: Epidemiology, pathophysiology, clinical manifestations, and management. Translational Research. 2014;164(4):345–356. https://doi.org/10.1016/j.trsl.2014.04.010.

    Article  PubMed  Google Scholar 

  71. Baena-Diez JM, Byram AO, Grau M, et al. Obesity is an independent risk factor for heart failure: Zona Franca cohort study. Clinical Investigations. 2010;33(12):760–764. https://doi.org/10.1002/clc.20837.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Alexander JK, Dennis EW, Smith WG, Amad KH, Duncan WC, Austin RC. Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovascular Research Center Bulletin. 1962;1:39–44.

    Google Scholar 

  73. Lyons OD, Bradley TD. Heart failure and sleep apnea. Canadian Journal of Cardiology. 2015;31(7):898–908. https://doi.org/10.1016/j.cjca.2015.04.017.

    Article  PubMed  Google Scholar 

  74. Holt A, Bjerre J, Zareini B, et al. Sleep apnea, the risk of developing heart failure, and potential benefits of continuous positive airway pressure (CPAP) therapy. Journal of the American Heart Association. 2018;7(13):e008684. https://doi.org/10.1161/jaha.118.008684.

  75. Grassi G, Seravalle G, Quarti-Trevano F, et al. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms. Hypertension. 2007;49(3):535–541. https://doi.org/10.1161/01.hyp.0000255983.32896.b9.

    Article  PubMed  Google Scholar 

  76. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: A meta-analysis. American Heart Journal. 2008;156(1):13–22. https://doi.org/10.1016/j.ahj.2008.02.014.

    Article  PubMed  Google Scholar 

  77. Poulain M, Doucet M, Major GC, et al. The effect of obesity on chronic respiratory diseases: Pathophysiology and therapeutic strategies. CMAJ: Canadian Medical Association Journal. 2006;174(9):1293–1299. https://doi.org/10.1503/cmaj.051299.

    Article  PubMed  Google Scholar 

  78. Melo LC, Silva MA, Calles AC. Obesity and lung function: A systematic review. Einstein (Sao Paulo). 2014;12(1):120–125. https://doi.org/10.1590/s1679-45082014rw2691.

    Article  Google Scholar 

  79. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: A meta-analysis of prospective epidemiologic studies. American Journal of Respiratory and Critical Care Medicine. 2007;175(7):661–666. https://doi.org/10.1164/rccm.200611-1717oc.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Peters U, Dixon AE, Forno E. Obesity and asthma. Journal of Allergy and Clinical Immunology. 2018;141(4):1169–1179. https://doi.org/10.1016/j.jaci.2018.02.004.

    Article  PubMed  Google Scholar 

  81. Lambert AA, Putcha N, Drummond MB, et al. Obesity is associated with increased morbidity in moderate to severe COPD. Chest. 2017;151(1):68–77. https://doi.org/10.1016/j.chest.2016.08.1432.

    Article  PubMed  Google Scholar 

  82. Divo MJ, Cabrera C, Casanova C, et al. Comorbidity distribution, clinical expression and survival in COPD patients with different body mass index. Chronic Obstructive Pulmonary Diseases. 2014;1(2):229–238. https://doi.org/10.15326/jcopdf.1.2.2014.0117.

    Article  PubMed  Google Scholar 

  83. Soylu AC, Levent E, Sariman N, Yurtlu S, Alparslan S, Saygi A. Obstructive sleep apnea syndrome and anthropometric obesity indexes. Sleep Breath. 2012;16(4):1151–1158. https://doi.org/10.1007/s11325-011-0623-9.

    Article  PubMed  Google Scholar 

  84. van der Spuy I, Zhao G, Karunanayake C, Pahwa P. Predictors of sleep apnea in the Canadian population. Canadian Respiratory Journal. 2018;2018:6349790. https://doi.org/10.1155/2018/6349790.

    Article  Google Scholar 

  85. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society. 2008;5(2):136–143. https://doi.org/10.1513/pats.200709-155mg.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Luyster FS, Kip KE, Buysse DJ, Aiyer AN, Reis SE, Strollo PJ, Jr. Traditional and nontraditional cardiovascular risk factors in comorbid insomnia and sleep apnea. Sleep. 2014;37(3):593–600. https://doi.org/10.5665/sleep.3506.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Wang Y, Li C, Feng L, Feng J, Cao J, Chen B. Prevalence of hypertension and circadian blood pressure variations in patients with obstructive sleep apnoea-hypopnoea syndrome. Journal of International Medical Research. 2014;42(3):773–780. https://doi.org/10.1177/0300060513516756.

    Article  PubMed  Google Scholar 

  88. Rezaeitalab F, Moharrari F, Saberi S, Asadpour H, Rezaeetalab F. The correlation of anxiety and depression with obstructive sleep apnea syndrome. Journal of Research in Medical Sciences. 2014;19(3):205–210.

    Google Scholar 

  89. Gottlieb DJ, Whitney CW, Bonekat WH, et al. Relation of sleepiness to respiratory disturbance index: The sleep heart health study. American Journal of Respiratory and Critical Care Medicine. 1999;159(2):502–507. https://doi.org/10.1164/ajrccm.159.2.9804051.

    Article  PubMed  Google Scholar 

  90. Mokhlesi B. Obesity hypoventilation syndrome: A state-of-the-art review. Respiratory Care. 2010;55(10):1347–1362; discussion 1363–1365.

    Google Scholar 

  91. Pierce AM, Brown LK. Obesity hypoventilation syndrome: Current theories of pathogenesis. Current Opinion in Pulmonary Medicine. 2015;21(6):557–562. https://doi.org/10.1097/mcp.0000000000000210.

    Article  PubMed  Google Scholar 

  92. Chang P, Friedenberg F. Obesity and GERD. Gastroenterology Clinics of North America. 2014;43(1):161–173. https://doi.org/10.1016/j.gtc.2013.11.009.

    Article  PubMed  Google Scholar 

  93. El-Serag H. The association between obesity and GERD: A review of the epidemiological evidence. Digestive Diseases and Sciences. 2008;53(9):2307–2312. https://doi.org/10.1007/s10620-008-0413-9.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Stein DJ, El-Serag HB, Kuczynski J, Kramer JR, Sampliner RE. The association of body mass index with Barrett’s oesophagus. Alimentary Pharmacology and Therapeutics. 2005;22(10):1005–1010. https://doi.org/10.1111/j.1365-2036.2005.02674.x.

    Article  PubMed  Google Scholar 

  95. Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: A pooled analysis from the International BEACON Consortium. International Journal of Epidemiology. 2012;41(6):1706–1718. https://doi.org/10.1093/ije/dys176.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. The American Journal of Clinical Nutrition. 1992;55(3):652–658. https://doi.org/10.1093/ajcn/55.3.652.

    Article  PubMed  Google Scholar 

  97. Bonfrate L, Wang DQ, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Practice & Research Clinical Gastroenterology. 2014;28(4):623–635. https://doi.org/10.1016/j.bpg.2014.07.013.

    Article  Google Scholar 

  98. Cruz-Monserrate Z, Conwell DL, Krishna SG. The impact of obesity on gallstone disease, acute pancreatitis, and pancreatic cancer. Gastroenterology Clinics. 2016;45(4):625–637. https://doi.org/10.1016/j.gtc.2016.07.010.

    Article  PubMed  Google Scholar 

  99. Sadr-Azodi O, Orsini N, Andren-Sandberg A, Wolk A. Abdominal and total adiposity and the risk of acute pancreatitis: A population-based prospective cohort study. American Journal of Gastroenterology. 2013;108(1):133–139. https://doi.org/10.1038/ajg.2012.381.

    Article  PubMed  Google Scholar 

  100. Krishna SG, Hinton A, Oza V, et al. Morbid obesity is associated with adverse clinical outcomes in acute pancreatitis: A propensity-matched study. The American Journal of Gastroenterology. 2015;110(11):1608–1619. https://doi.org/10.1038/ajg.2015.343.

    Article  PubMed  Google Scholar 

  101. Martinez J, Johnson CD, Sanchez-Paya J, de Madaria E, Robles-Diaz G, Perez-Mateo M. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: An updated meta-analysis. Pancreatology. 2006;6(3):206–209. https://doi.org/10.1159/000092104.

    Article  PubMed  Google Scholar 

  102. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology. 2011;140(1):124–131. https://doi.org/10.1053/j.gastro.2010.09.038.

    Article  PubMed  Google Scholar 

  103. Wong VW, Chitturi S, Wong GL, Yu J, Chan HL, Farrell GC. Pathogenesis and novel treatment options for non-alcoholic steatohepatitis. The Lancet Gastroenterology & Hepatology. 2016;1(1):56–67. https://doi.org/10.1016/s2468-1253(16)30011-5.

    Article  Google Scholar 

  104. Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nature Reviews Nephrology. 2016;12(2):73–81. https://doi.org/10.1038/nrneph.2015.173.

    Article  PubMed  Google Scholar 

  105. Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering Committee. Obesity and kidney disease: Hidden consequences of the epidemic. Kidney International. 2017;91(2):260–262. https://doi.org/10.1016/j.kint.2016.10.019.

    Article  PubMed  Google Scholar 

  106. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: A systematic review and meta-analysis. Kidney International. 2008;73(1):19–33. https://doi.org/10.1038/sj.ki.5002586.

    Article  PubMed  Google Scholar 

  107. George MD, Baker JF. The obesity epidemic and consequences for rheumatoid arthritis care. Current Rheumatology Reports. 2016;18(1):6. https://doi.org/10.1007/s11926-015-0550-z.

  108. Bliddal H, Leeds AR, Christensen R. Osteoarthritis, obesity and weight loss: Evidence, hypotheses and horizons—A scoping review. Obesity Reviews. 2014;15(7):578–586. https://doi.org/10.1111/obr.12173.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Wannamethee SG, Atkins JL. Muscle loss and obesity: The health implications of sarcopenia and sarcopenic obesity. Proceedings of the Nutrition Society. 2015;74(4):405–412. https://doi.org/10.1017/s002966511500169x.

    Article  PubMed  Google Scholar 

  110. Li X, Gong X, Jiang W. Abdominal obesity and risk of hip fracture: A meta-analysis of prospective studies. Osteoporosis International. 2017;28(10):2747–2757. https://doi.org/10.1007/s00198-017-4142-9.

    Article  PubMed  Google Scholar 

  111. Cicuttini FM, Wluka AE. Not just loading and age: The dynamics of osteoarthritis, obesity and inflammation. Medical Journal of Australia. 2016;204(2):47. https://doi.org/10.5694/mja15.01069.

    Article  PubMed  Google Scholar 

  112. Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee osteoarthritis: The Framingham study. Annals of Internal Medicine. 1988;109(1):18–24. https://doi.org/10.7326/0003-4819-109-1-18.

    Article  PubMed  Google Scholar 

  113. Godziuk K, Prado CM, Woodhouse LJ, Forhan M. The impact of sarcopenic obesity on knee and hip osteoarthritis: A scoping review. BMC Musculoskeletal Disorders. 2018;19(1):271. https://doi.org/10.1186/s12891-018-2175-7.

  114. Batsis JA, Zbehlik AJ, Barre LK, Bynum JP, Pidgeon D, Bartels SJ. Impact of obesity on disability, function, and physical activity: Data from the osteoarthritis initiative. Scandinavian Journal of Rheumatology. 2015;44(6):495–502. https://doi.org/10.3109/03009742.2015.1021376.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Qin B, Yang M, Fu H, et al. Body mass index and the risk of rheumatoid arthritis: A systematic review and dose-response meta-analysis. Arthritis Research & Therapy. 2015;17(1):86. https://doi.org/10.1186/s13075-015-0601-x.

  116. Kaze AD, Rosen HN, Paik JM. A meta-analysis of the association between body mass index and risk of vertebral fracture. Osteoporosis International. 2018;29(1):31–39. https://doi.org/10.1007/s00198-017-4294-7.

    Article  PubMed  Google Scholar 

  117. Scott D, Chandrasekara SD, Laslett LL, Cicuttini F, Ebeling PR, Jones G. Associations of sarcopenic obesity and dynapenic obesity with bone mineral density and incident fractures over 5–10 years in community-dwelling older adults. Calcified Tissue International. 2016;99(1):30–42. https://doi.org/10.1007/s00223-016-0123-9.

    Article  PubMed  Google Scholar 

  118. Scott D, Seibel M, Cumming R, et al. Sarcopenic obesity and its temporal associations with changes in bone mineral density, incident falls, and fractures in older men: The concord health and ageing in men project. Journal of Bone and Mineral Research. 2017;32(3):575–583. https://doi.org/10.1002/jbmr.3016.

    Article  PubMed  Google Scholar 

  119. Lima AL, Illing T, Schliemann S, Elsner P. Cutaneous manifestations of diabetes mellitus: A review. Journal of the American Academy of Dermatology. 2017;18(4):541–553. https://doi.org/10.1007/s40257-017-0275-z.

    Article  PubMed  Google Scholar 

  120. Furue M, Tsuji G, Chiba T, Kadono T. Cardiovascular and metabolic diseases comorbid with psoriasis: Beyond the skin. Internal Medicine. 2017;56(13):1613–1619. https://doi.org/10.2169/internalmedicine.56.8209.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Karimi K, Lindgren TH, Koch CA, Brodell RT. Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer. Reviews in Endocrine and Metabolic Disorders. 2016;17(3):389–403. https://doi.org/10.1007/s11154-016-9393-9.

    Article  PubMed  Google Scholar 

  122. Rodino IS, Byrne S, Sanders KA. Obesity and psychological wellbeing in patients undergoing fertility treatment. Reproductive Biomedicine Online. 2016;32(1):104–112. https://doi.org/10.1016/j.rbmo.2015.10.002.

    Article  PubMed  Google Scholar 

  123. Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian obstetric population. Medical Journal of Australia. 2006;184(2):56–59. https://doi.org/10.5694/j.1326-5377.2006.tb00115.x.

    Article  PubMed  Google Scholar 

  124. Dodd JM, Grivell RM, Nguyen AM, Chan A, Robinson JS. Maternal and perinatal health outcomes by body mass index category. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2011;51(2):136–140. https://doi.org/10.1111/j.1479-828x.2010.01272.x.

    Article  PubMed  Google Scholar 

  125. Moore LL, Singer MR, Bradlee ML, Rothman KJ, Milunsky A. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology. 2000;11(6):689–694.

    Article  PubMed  Google Scholar 

  126. Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-income countries: A systematic review and meta-analysis. The Lancet. 2011;377(9774):1331–1340. https://doi.org/10.1016/s0140-6736(10)62233-7.

    Article  Google Scholar 

  127. Drake AJ, Reynolds RM. Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction. 2010;140(3):387–398. https://doi.org/10.1530/rep-10-0077.

    Article  PubMed  Google Scholar 

  128. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. The American Journal of Medicine. 2005;118(9):978–980. https://doi.org/10.1016/j.amjmed.2005.03.012.

    Article  PubMed  Google Scholar 

  129. Samad F, Ruf W. Inflammation, obesity, and thrombosis. Blood. 2013;122(20):3415–3422. https://doi.org/10.1182/blood-2013-05-427708.

    Article  PubMed  PubMed Central  Google Scholar 

  130. Hunt BJ. Hemostasis at extremes of body weight. Seminars in Thrombosis and Hemostasis. 2018;44(7):632–639. https://doi.org/10.1055/s-0038-1661385.

    Article  PubMed  Google Scholar 

  131. Zhao L, Zhang X, Shen Y, Fang X, Wang Y, Wang F. Obesity and iron deficiency: A quantitative meta-analysis. Obesity Reviews. 2015;16(12):1081–1093. https://doi.org/10.1111/obr.12323.

    Article  PubMed  Google Scholar 

  132. Soderberg KC, Kaprio J, Verkasalo PK, et al. Overweight, obesity and risk of haematological malignancies: A cohort study of Swedish and Finnish twins. European Journal of Cancer. 2009;45(7):1232–1238. https://doi.org/10.1016/j.ejca.2008.11.004.

    Article  PubMed  Google Scholar 

  133. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer—Viewpoint of the IARC Working Group. New England Journal of Medicine. 2016;375(8):794–798. https://doi.org/10.1056/nejmsr1606602.

    Article  PubMed  Google Scholar 

  134. Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: Analysis of a population-based cancer registry. The Lancet Public Health. 2019;4(3):e137–e147. https://doi.org/10.1016/s2468-2667(18)30267-6.

    Article  PubMed  Google Scholar 

  135. Avila C, Holloway AC, Hahn MK, et al. An overview of links between obesity and mental health. Current Obesity Reports. 2015;4(3):303–310. https://doi.org/10.1007/s13679-015-0164-9.

    Article  PubMed  Google Scholar 

  136. Cortese S, Tessari L. Attention-deficit/hyperactivity disorder (ADHD) and obesity: Update 2016. Current Psychiatry Reports. 2017;19(4). https://doi.org/10.1007/s11920-017-0754-1.

  137. Chouinard VA, Pingali SM, Chouinard G, et al. Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders. Psychiatry Research. 2016;237:304–310. https://doi.org/10.1016/j.psychres.2016.01.024.

    Article  PubMed  Google Scholar 

  138. Bartoli F, Crocamo C, Alamia A, et al. Posttraumatic stress disorder and risk of obesity: Systematic review and meta-analysis. The Journal of Clinical Psychiatry. 2015;76(10):e1253–e1261. https://doi.org/10.4088/jcp.14r09199.

    Article  PubMed  Google Scholar 

  139. Strassnig M, Kotov R, Cornaccio D, Fochtmann L, Harvey PD, Bromet EJ. Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis. Bipolar Disorders. 2017;19(5):336–343. https://doi.org/10.1111/bdi.12505.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Manu P, Dima L, Shulman M, Vancampfort D, De Hert M, Correll CU. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatrica Scandinavica. 2015;132(2):97–108. https://doi.org/10.1111/acps.12445.

    Article  PubMed  Google Scholar 

  141. Wang Y, Wu B, Yang H, Song X. The effect of childhood abuse on the risk of adult obesity. Annals of Clinical Psychiatry. 2015;27(3):175–184.

    Google Scholar 

  142. Hasnain M, Vieweg WV. Weight considerations in psychotropic drug prescribing and switching. Postgraduate Medicine. 2013;125(5):117–129. https://doi.org/10.3810/pgm.2013.09.2706.

    Article  PubMed  Google Scholar 

  143. Kokkoris P, Pi-Sunyer FX. Obesity and endocrine disease. Endocrinology and Metabolism Clinics of North America. 2003;32(4):895–914. https://doi.org/10.1016/s0889-8529(03)00078-1.

    Article  PubMed  Google Scholar 

  144. Oussaada SM, van Galen KA, Cooiman MI, et al. The pathogenesis of obesity. Metabolism. 2019;92:26–36. https://doi.org/10.1016/j.metabol.2018.12.012.

    Article  PubMed  Google Scholar 

  145. Owen L, Corfe B. The role of diet and nutrition on mental health and wellbeing. Proceedings of the Nutrition Society. 2017;76(4):425–426. https://doi.org/10.1017/s0029665117001057.

    Article  PubMed  Google Scholar 

  146. Brown RF, Thorsteinsson EB, Smithson M, Birmingham CL, Aljarallah H, Nolan C. Can body temperature dysregulation explain the co-occurrence between overweight/obesity, sleep impairment, late-night eating, and a sedentary lifestyle? Eat Weight Disorders. 2017;22(4):599–608. https://doi.org/10.1007/s40519-017-0439-0.

    Article  Google Scholar 

  147. Dulloo AG, Miles-Chan JL, Montani JP. Nutrition, movement and sleep behaviours: Their interactions in pathways to obesity and cardiometabolic diseases. Obesity Reviews. 2017;18(Suppl 1):3–6. https://doi.org/10.1111/obr.12513.

    Article  PubMed  Google Scholar 

  148. Stanley SH, Laugharne JD, Addis S, Sherwood D. Assessing overweight and obesity across mental disorders: Personality disorders at high risk. Social Psychiatry and Psychiatric Epidemiology. 2013;48(3):487–492. https://doi.org/10.1007/s00127-012-0546-1.

    Article  PubMed  Google Scholar 

  149. Gluckman PD, Hanson MA, Buklijas T, Low FM, Beedle AS. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nature Reviews Endocrinology. 2009;5(7):401–408. https://doi.org/10.1038/nrendo.2009.102.

    Article  PubMed  Google Scholar 

  150. Skilton MR, Moulin P, Terra J-L, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biological Psychiatry. 2007;62(11):1251–1257. https://doi.org/10.1016/j.biopsych.2007.01.012.

    Article  PubMed  Google Scholar 

  151. Pan A, Keum N, Okereke OI, et al. Bidirectional association between depression and metabolic syndrome: A systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012;35(5):1171–1180. https://doi.org/10.2337/dc11-2055.

    Article  PubMed  PubMed Central  Google Scholar 

  152. Mireku MO, Barker MM, Mutz J, et al. Night-time screen-based media device use and adolescents’ sleep and health-related quality of life. Environment International. 2019;124:66–78. https://doi.org/10.1016/j.envint.2018.11.069.

    Article  PubMed  Google Scholar 

  153. Dominoni DM, Borniger JC, Nelson RJ. Light at night, clocks and health: From humans to wild organisms. Biology Letters. 2016;12(2):20160015. https://doi.org/10.1098/rsbl.2016.0015.

    Article  PubMed  PubMed Central  Google Scholar 

  154. Blauw LL, Aziz NA, Tannemaat MR, et al. Diabetes incidence and glucose intolerance prevalence increase with higher outdoor temperature. BMJ Open Diabetes Research & Care. 2017;5(1):e000317. https://doi.org/10.1136/bmjdrc-2016-000317.

    Article  Google Scholar 

  155. Kenny GP, Sigal RJ, McGinn R. Body temperature regulation in diabetes. Temperature. 2016;3(1):119–145. https://doi.org/10.1080/23328940.2015.1131506.

    Article  Google Scholar 

  156. Wang F, Zhang L, Zhang Y, et al. Meta-analysis on night shift work and risk of metabolic syndrome. Obesity Reviews. 2014;15(9):709–720. https://doi.org/10.1111/obr.12194.

    Article  PubMed  Google Scholar 

  157. Bijlenga D, van der Heijden KB, Breuk M, et al. Associations between sleep characteristics, seasonal depressive symptoms, lifestyle, and ADHD symptoms in adults. Journal of Attention Disorders. 2013;17(3):261–275. https://doi.org/10.1177/1087054711428965.

    Article  PubMed  Google Scholar 

  158. Lonardo A, Nascimbeni F, Mantovani A, Targher G. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? Journal of Hepatology. 2018;68(2):335–352. https://doi.org/10.1016/j.jhep.2017.09.021.

    Article  PubMed  Google Scholar 

  159. Kerekes G, Nurmohamed MT, Gonzalez-Gay MA, et al. Rheumatoid arthritis and metabolic syndrome. Nature Reviews Rheumatology. 2014;10(11):691–696. https://doi.org/10.1038/nrrheum.2014.121.

    Article  PubMed  Google Scholar 

  160. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: A systematic review and meta-analysis. Diabetes Care. 2012;35(11):2402–2411. https://doi.org/10.2337/dc12-0336.

    Article  PubMed  PubMed Central  Google Scholar 

  161. Margini C, Dufour JF. The story of HCC in NAFLD: From epidemiology, across pathogenesis, to prevention and treatment. Liver International. 2016;36(3):317–324. https://doi.org/10.1111/liv.13031.

    Article  PubMed  Google Scholar 

  162. Tabak AG, Akbaraly TN, Batty GD, Kivimaki M. Depression and type 2 diabetes: A causal association? The Lancet Diabetes & Endocrinology. 2014;2(3):236–245. https://doi.org/10.1016/s2213-8587(13)70139-6.

    Article  Google Scholar 

  163. Calders P, Van Ginckel A. Presence of comorbidities and prognosis of clinical symptoms in knee and/or hip osteoarthritis: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 2018;47(6):805–813. https://doi.org/10.1016/j.semarthrit.2017.10.016.

    Article  PubMed  Google Scholar 

  164. Suri P, Morgenroth DC, Hunter DJ. Epidemiology of osteoarthritis and associated comorbidities. PM&R. 2012;4(5 Suppl):S10–S19. https://doi.org/10.1016/j.pmrj.2012.01.007.

    Article  Google Scholar 

  165. Reith J, Jorgensen HS, Pedersen PM, et al. Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality, and outcome. The Lancet. 1996;347(8999):422–425. https://doi.org/10.1016/s0140-6736(96)90008-2.

    Article  Google Scholar 

  166. Catala-Lopez F, Alonso-Arroyo A, Page MJ, Hutton B, Tabares-Seisdedos R, Aleixandre-Benavent R. Mapping of global scientific research in comorbidity and multimorbidity: A cross-sectional analysis. PLOS One. 2018;13(1):e0189091. https://doi.org/10.1371/journal.pone.0189091.

    Article  PubMed  PubMed Central  Google Scholar 

  167. Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. British Medical Journal. 2015;350:h176. https://doi.org/10.1136/bmj.h176.

    Article  PubMed  Google Scholar 

  168. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: Implications for understanding health and health services. The Annals of Family Medicine. 2009;7(4):357–363. https://doi.org/10.1370/afm.983.

    Article  PubMed  Google Scholar 

  169. McDaid D, Park A-L. Counting all the costs: The economic impact of comorbidity. In: Sartorius N, Holt RIG, Maj M, eds., Comorbidity of mental and physical disorders: Key issues mental health. Vol. 179. Basel, Switzerland: Karger 2015:23–32.

    Google Scholar 

  170. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Medical Care. 1998;36(1):8–27.

    Article  PubMed  Google Scholar 

  171. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases. 1987;40(5):373–383. https://doi.org/10.1016/0021-9681(87)90171-8.

    Article  Google Scholar 

  172. Lebenbaum M, Zaric GS, Thind A, Sarma S. Trends in obesity and multimorbidity in Canada. Preventive Medicine. 2018;116:173–179. https://doi.org/10.1016/j.ypmed.2018.08.025.

    Article  PubMed  Google Scholar 

  173. Borrell LN, Samuel L. Body mass index categories and mortality risk in US adults: The effect of overweight and obesity on advancing death. American Journal of Public Health. 2014;104(3):512–519. https://doi.org/10.2105/ajph.2013.301597.

    Article  PubMed  PubMed Central  Google Scholar 

  174. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. The New England Journal of Medicine. 2010;363(23):2211–2219. https://doi.org/10.1056/nejmoa1000367.

    Article  PubMed  Google Scholar 

  175. Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases. The Lancet Diabetes & Endocrinology. 2014;2(10):819–829. https://doi.org/10.1016/s2213-8587(14)70034-8.

    Article  Google Scholar 

  176. Liguori I, Russo G, Aran L, et al. Sarcopenia: Assessment of disease burden and strategies to improve outcomes. Clinical Interventions in Aging. 2018;13:913–927. https://doi.org/10.2147/cia.s149232.

    Article  Google Scholar 

  177. Abramowitz MK, Hall CB, Amodu A, Sharma D, Androga L, Hawkins M. Muscle mass, BMI, and mortality among adults in the United States: A population-based cohort study. PLOS One. 2018;13(4):e0194697. https://doi.org/10.1371/journal.pone.0194697.

    Article  PubMed  PubMed Central  Google Scholar 

  178. Gunn JM, Ayton DR, Densley K, et al. The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort. Social Psychiatry and Psychiatric Epidemiology. 2012;47(2):175–184. https://doi.org/10.1007/s00127-010-0330-z.

    Article  PubMed  Google Scholar 

  179. Schoepf D, Heun R. Bipolar disorder and comorbidity: Increased prevalence and increased relevance of comorbidity for hospital-based mortality during a 12.5-year observation period in general hospital admissions. Journal of Affective Disorders. 2014;169:170–178. https://doi.org/10.1016/j.jad.2014.08.025.

    Article  PubMed  Google Scholar 

  180. Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. New England Journal of Medicine. 2017;376(3):254–266. https://doi.org/10.1056/nejmra1514009.

    Article  PubMed  Google Scholar 

  181. Jakobsen GS, Smastuen MC, Sandbu R, et al. Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities. The Journal of the American Medical Association. 2018;319(3):291–301. https://doi.org/10.1001/jama.2017.21055.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Australian National University, Canberra, ACT, Australia

    Christopher J. Nolan

Authors
  1. Christopher J. Nolan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher J. Nolan .

Editor information

Editors and Affiliations

  1. Research School of Psychology, Australian National University, Canberra, ACT, Australia

    Rhonda Brown

  2. School of Psychology, University of New England, Armidale, NSW, Australia

    Einar Thorsteinsson

Rights and permissions

Reprints and permissions

Copyright information

© 2020 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nolan, C.J. (2020). Overview of the Comorbidity Between Medical Illnesses and Overweight/Obesity. In: Brown, R., Thorsteinsson, E. (eds) Comorbidity. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-030-32545-9_4

Download citation

Publish with us

Policies and ethics

Search

Navigation